FDA — authorised 2 June 1994
- Application: NDA020314
- Marketing authorisation holder: CURIUM
- Local brand name: OCTREOSCAN
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Octreoscan in United States
FDA authorised Octreoscan on 2 June 1994
Marketing authorisations
FDA
- Marketing authorisation holder: SUN PHARM INDS INC
- Status: approved
Octreoscan in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Octreoscan approved in United States?
Yes. FDA authorised it on 2 June 1994; FDA has authorised it.
Who is the marketing authorisation holder for Octreoscan in United States?
CURIUM holds the US marketing authorisation.